University of California, San Diego

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of California, San Diego sits in the top decile of US sponsors by registered trial count (#43 of 15,742 sponsors by registered trial count).

775 total trials 143 currently recruiting 499 completed early-phase tilt top decile by trial count

University of California, San Diego: 775 sponsored US clinical trials, 143 recruiting.

University of California, San Diego sponsors 775 registered US clinical trials on ClinicalTrials.gov, 143 of them currently recruiting, and 499 completed. 104 of these trials are in Phase 3-4 (later-stage) and 170 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Anorexia Nervosa, with 10 trials.

Top-decile sponsor footprint

University of California, San Diego ranks in the top decile of sponsors by registered trial count (#43 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 65/100

499 of 553 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

775 total, page 8 of 16

TERMINATED

An Open Label Navigational Investigation of Molecular Profile-Related Evidence Determining Individualized Cancer Therapy for Patients With Incurable Hematologic Malignancies (I-PREDICT Heme)

NCT03955276

TERMINATED NA

Effects of Triphala and VSL#3 Probiotic Supplementation on Stool Microbiome Profiles and Inflammation

NCT03907501

COMPLETED Phase 1

Trial of Cannabis for Essential Tremor

NCT03805750

COMPLETED

Sleep Disordered Breathing in Acute Congestive Heart Failure

NCT03804827

COMPLETED NA

Acceptance and Commitment Therapy for Aging People Living With HIV in Chronic Pain

NCT03699020

COMPLETED NA

The "Step4Life" Randomized Control Trial in Hemodialysis

NCT05241171

COMPLETED NA

Study Comparing the Effects of Latanoprostene Bunod and Timolol on Retinal Blood Vessel Density and Visual Acuity

NCT03931317

COMPLETED NA

iSTEP - an mHealth Physical Activity and Diet Intervention for Persons With HIV

NCT03123731

COMPLETED NA

Mobile Web-based Behavioral Intervention for Improving Caregiver Well-being

NCT03506945

COMPLETED Phase 3

Effect of Paracervical Block Volume on Pain Control for Dilation and Curettage.o

NCT03636451

TERMINATED Phase 2

Daratumumab, Ixazomib, Pomalidomide, and Dexamethasone as Salvage Therapy in Relapsed/Refractory Multiple Myeloma

NCT03590652

COMPLETED Phase 4

Modafinil Effects on EEG Biomarkers of Reward and Motivation

NCT03616717

COMPLETED Phase 1

Dapagliflozin Effects on Hypoglycemia

NCT03704818

COMPLETED NA

CHARGE: Controlling Hunger and ReGulating Eating

NCT03678766

COMPLETED NA

Jovenes Sanos: Preventing IPV and RC

NCT03660514

COMPLETED NA

Effect of Anti-inflammatory (ITIS) Diet in Rheumatoid Arthritis

NCT04999683

COMPLETED NA

Cryoanalgesia to Prevent Acute and Chronic Pain Following Surgery: A Randomized, Double-Masked, Sham-Controlled Study

NCT03578237

COMPLETED

Obstructive Sleep Apnea Endotypes and Impact on Phenotypes of People Living With HIV

NCT03575143

COMPLETED NA

Weight Management in Mothers and Adult Daughters

NCT02787902

COMPLETED NA

Ultrasound-Guided Percutaneous Peripheral Nerve Stimulation: A Department of Defense Funded Multicenter Pilot Study

NCT03481725

COMPLETED NA

Precision Approach to PPI Therapy in Gastroesophageal Reflux Disease

NCT03619811

COMPLETED Phase 4

Erector Spinae Versus Paravertebral Nerve Blocks for Breast Surgery

NCT03549234

COMPLETED Phase 2

Effect of Cannabis and Endocannabinoids on HIV Neuropathic Pain

NCT03099005

COMPLETED NA

Addressing Reproductive Coercion in HEalth Settings - Kenya

NCT03534401

COMPLETED NA

Sedentary Behavior Interrupted Randomized Controlled Trial (P2)

NCT03473145

COMPLETED NA

The Healthy Heroes Study

NCT03533023

COMPLETED NA

Overcoming Pain Through Yoga in the Military

NCT03504085

TERMINATED NA

Measuring Sweat Glucose of Patients With Diabetes - The ENGAGE Study

NCT03460964

COMPLETED Phase 4

Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients With Cirrhosis

NCT04288323

TERMINATED NA

Impact of Non-invasive Ventilation in Hypercapnic COPD

NCT03522805

COMPLETED NA

Brain Mechanisms Supporting Meditation-based Analgesia

NCT03414138

COMPLETED NA

Comparing Through-the-Needle With Suture-Method Catheter Designs for Popliteal Nerve Blocks

NCT03442036

COMPLETED NA

UCSD Get Fit, Be Fit Study

NCT03387709

COMPLETED NA

Novel Behavioral Intervention to Enhance Social Connections in Anxiety and Depression

NCT03196544

COMPLETED NA

Correlating Probiotic Dietary Supplements During Pregnancy With Maternal Microbiome Profiles

NCT03611647

COMPLETED Phase 4

Memantine Effects on Sensorimotor Gating and Neurocognition in Schizophrenia

NCT03860597

COMPLETED NA

Cryoanalgesia to Treat Post-Amputation Phantom Limb Pain: A Department of Defense Funded Multicenter Study

NCT03449667

COMPLETED NA

Early vs. Interval Postpartum IUD Insertion

NCT03462758

TERMINATED Phase 2

Phase 2 RCT of Alvimopan vs. Placebo After CRS/HIPEC

NCT03352414

COMPLETED NA

Development of a Mobile Heath Augmented Brief Suicide Prevention Intervention for People With SMI

NCT03198364

COMPLETED NA

A Neurofeedback Intervention to Improve Working Memory in Schizophrenia

NCT03260257

COMPLETED Phase 3

Effect of Ivabradine on Patients With Postural Orthostatic Tachycardia Syndrome

NCT03182725

COMPLETED NA

OPEN & ASK: Improving Patient-Centered Communication in Primary Care

NCT03385512

COMPLETED

Contraception for Solid Organ Transplant Patients: Utilizing Social Media

NCT03979950

COMPLETED NA

Low-dose CT-based Method for Detection of Subclinical Anthracycline-induced Cardiotoxicity

NCT03553654

COMPLETED Phase 1

Obinutuzumab, High Dose Methylprednisolone (HDMP), and Lenalidomide for the Treatment of Patients With Richter's Syndrome

NCT03113695

TERMINATED Early Phase 1

Hyperbaric Oxygen Therapy for Inflammatory Conditions of the Urinary Bladder

NCT03143920

TERMINATED NA

Independent Walking for Brain Health

NCT03058146

TERMINATED

Modeling the Neurological Basis and Characterizing the Neurological Phenotype of Obesity Using Human Neural Stem Cells

NCT03263390

COMPLETED NA

Fit for Two: Incorporating Wearable Trackers Into Clinical Care for Pregnant Women With Diabetes (FFT)

NCT03302377

← Previous Page 8 of 16 Next →

Phase Distribution

PhaseTrial count
Phase 1 80
Phase 2 90
Phase 3 22
Phase 4 82

What is open in the University of California, San Diego pipeline

143 recruiting of 775 indexed (18% open); 499 completed (64%).

Phase mix: 104 late (III/IV) vs 170 early (I/II) (early-phase heavy).

Top condition: Anorexia Nervosa (10 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of California, San Diego: open-pipeline peers nationwide

Peers matched on 775 registered trials and 18% open enrollment, not the therapeutic-area sidebar.

University of California, San Diego sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 02004006008001,000 14%16%18%20%22% Total trials Recruiting share University of California, San DiegoDana-Farber Cancer InstituteMedical University of South CarolinaUniversity of ChicagoUniversity of UtahNeurocrine BiosciencesThomas Jefferson UniversityAbramson Cancer Center at Penn MedicineUniversity of Maryland, Baltimore
University of California, San Diego sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of California, San Diego sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 775 trials (± recruiting share)

Sponsors near 18% open enrollment (± trial volume)

What to do with this University of California, San Diego page

775 registered trials is a research-attention snapshot, not an endorsement of University of California, San Diego or any single study.

  • 143 of University of California, San Diego's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Anorexia Nervosa is the condition University of California, San Diego studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Anorexia Nervosa trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, San Diego pipeline card: 775 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.